These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 14990565)
1. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. El-Tanani M; Platt-Higgins A; Rudland PS; Campbell FC J Biol Chem; 2004 May; 279(20):20794-806. PubMed ID: 14990565 [TBL] [Abstract][Full Text] [Related]
2. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Crawford HC; Fingleton B; Gustavson MD; Kurpios N; Wagenaar RA; Hassell JA; Matrisian LM Mol Cell Biol; 2001 Feb; 21(4):1370-83. PubMed ID: 11158322 [TBL] [Abstract][Full Text] [Related]
3. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters. Gustavson MD; Crawford HC; Fingleton B; Matrisian LM Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508 [TBL] [Abstract][Full Text] [Related]
4. Pregnane and Xenobiotic Receptor gene expression in liver cells is modulated by Ets-1 in synchrony with transcription factors Pax5, LEF-1 and c-Jun. Kumari S; Saradhi M; Rana M; Chatterjee S; Aumercier M; Mukhopadhyay G; Tyagi RK Exp Cell Res; 2015 Jan; 330(2):398-411. PubMed ID: 25265064 [TBL] [Abstract][Full Text] [Related]
5. Pea3 transcription factor cooperates with USF-1 in regulation of the murine bax transcription without binding to an Ets-binding site. Firlej V; Bocquet B; Desbiens X; de Launoit Y; Chotteau-Lelièvre A J Biol Chem; 2005 Jan; 280(2):887-98. PubMed ID: 15466854 [TBL] [Abstract][Full Text] [Related]
6. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells. Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231 [TBL] [Abstract][Full Text] [Related]
7. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. Vadlamudi U; Espinoza HM; Ganga M; Martin DM; Liu X; Engelhardt JF; Amendt BA J Cell Sci; 2005 Mar; 118(Pt 6):1129-37. PubMed ID: 15728254 [TBL] [Abstract][Full Text] [Related]
9. TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent. Vietor I; Kurzbauer R; Brosch G; Huber LA J Biol Chem; 2005 Dec; 280(48):39795-801. PubMed ID: 16204248 [TBL] [Abstract][Full Text] [Related]
10. Polyoma enhancer activator 3, an ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells. Liu Y; Borchert GL; Phang JM J Biol Chem; 2004 Apr; 279(18):18694-700. PubMed ID: 14976201 [TBL] [Abstract][Full Text] [Related]
11. Cloning of the rat beta-catenin gene (Ctnnb1) promoter and its functional analysis compared with the Catnb and CTNNB1 promoters. Li Q; Dashwood WM; Zhong X; Al-Fageeh M; Dashwood RH Genomics; 2004 Feb; 83(2):231-42. PubMed ID: 14706452 [TBL] [Abstract][Full Text] [Related]
12. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells. Renault MA; Jalvy S; Belloc I; Pasquet S; Sena S; Olive M; Desgranges C; Gadeau AP Circ Res; 2003 Oct; 93(7):674-81. PubMed ID: 12970113 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229 [TBL] [Abstract][Full Text] [Related]
14. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1. Henderson BR; Galea M; Schuechner S; Leung L J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304 [TBL] [Abstract][Full Text] [Related]
15. Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities. Bidder M; Shao JS; Charlton-Kachigian N; Loewy AP; Semenkovich CF; Towler DA J Biol Chem; 2002 Nov; 277(46):44485-96. PubMed ID: 12200434 [TBL] [Abstract][Full Text] [Related]
16. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression. El-Tanani MK; Jin D; Campbell FC; Johnston PG Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966 [TBL] [Abstract][Full Text] [Related]
17. A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway. Grueneberg DA; Pablo L; Hu KQ; August P; Weng Z; Papkoff J Mol Cell Biol; 2003 Jun; 23(11):3936-50. PubMed ID: 12748295 [TBL] [Abstract][Full Text] [Related]
18. Metastasis-inducing dna regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4. El-Tanani M; Barraclough R; Wilkinson MC; Rudland PS Cancer Res; 2001 Jul; 61(14):5619-29. PubMed ID: 11454716 [TBL] [Abstract][Full Text] [Related]
19. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell. Guo X; Zhang YP; Mitchell DA; Denhardt DT; Chambers AF Mol Cell Biol; 1995 Jan; 15(1):476-87. PubMed ID: 7799957 [TBL] [Abstract][Full Text] [Related]
20. PEA3 cooperates with c-Jun in regulation of HER2/neu transcription. Matsui K; Sugimori K; Motomura H; Ejiri N; Tsukada K; Kitajima I Oncol Rep; 2006 Jul; 16(1):153-8. PubMed ID: 16786139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]